BE hopes to roll out COVID-19 vaccine Corbevax by November-end
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
Stay updated with breaking news from Be Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
The United States International Development Finance Corporation (DFC) and Hyderabad-based Biological E Limited on Monday signed a $50 million financing agreement to expand Covid-19 vaccine manufacturing capabilities in India.DFC Chief Operating ...
In a major boost to Covid-19 vaccine production in India, Hyderabad-based Biological E Limited will receive $50 million assistance from the United States International Development Finance Corporation (DFC).DFC Chief Operating Officer David ...
In a major boost to Covid 19 vaccine production in India Hyderabad based Biological E Limited will receive 50 million assistance from the United States International Development Finance Corporation DFC